Beam Therapeutics Inc. (BEAM)
Largest Insider Buys in Sector
BEAM Stock Price History Chart
BEAM Stock Performance
About Beam Therapeutics Inc.
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia; and BEAM-301, a liver-targeted development candidate for the treatment of patients with Glycogen Storage …
Insider Activity of Beam Therapeutics Inc.
Over the last 12 months, insiders at Beam Therapeutics Inc. have bought $0 and sold $38.57M worth of Beam Therapeutics Inc. stock.
On average, over the past 5 years, insiders at Beam Therapeutics Inc. have bought $0 and sold $25.6M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
List of Insider Buy and Sell Transactions, Beam Therapeutics Inc.
| 2024-11-06 | Sale | President | 51,110 0.0594% | $26.36 | $1.35M | +1.65% | ||
| 2024-10-14 | Sale | President | 51,110 0.0592% | $26.27 | $1.34M | -2.22% | ||
| 2024-10-01 | Sale | Chief Legal Officer | 385 0.0004% | $23.48 | $9,040 | +8.03% | ||
| 2024-10-01 | Sale | SVP, Finance and Treasurer | 289 0.0003% | $23.48 | $6,785 | +8.03% | ||
| 2024-09-30 | Sale | CEO | 60,000 0.0651% | $24.60 | $1.48M | +2.73% | ||
| 2024-07-02 | Sale | Chief Medical Officer | 748 0.0008% | $22.95 | $17,167 | +12.12% | ||
| 2024-07-01 | Sale | Chief Medical Officer | 502 0.0005% | $23.76 | $11,928 | +9.72% | ||
| 2024-06-27 | Sale | CEO | 60,000 0.0649% | $24.50 | $1.47M | +4.75% | ||
| 2024-04-02 | Sale | Chief Medical Officer | 16,530 0.0223% | $30.54 | $504,851 | -19.74% | ||
| 2024-04-01 | Sale | CEO | 18,102 0.0257% | $32.13 | $581,617 | -24.91% | ||
| 2024-04-01 | Sale | President | 4,534 0.0064% | $32.12 | $145,632 | -24.91% | ||
| 2024-04-01 | Sale | Chief Legal Officer | 3,401 0.0048% | $32.12 | $109,240 | -24.91% | ||
| 2024-04-01 | Sale | Chief Medical Officer | 7,157 0.0101% | $32.13 | $229,954 | -24.91% | ||
| 2024-04-01 | Sale | Chief Financial Officer | 5,446 0.0077% | $32.12 | $174,926 | -24.91% | ||
| 2024-03-28 | Sale | CEO | 60,000 0.0896% | $33.86 | $2.03M | -25.76% | ||
| 2024-02-14 | Sale | See Remark 1 | 900,000 1.2132% | $30.55 | $27.5M | -19.94% | ||
| 2024-02-13 | Sale | See Remark 1 | 1,565 0.0021% | $30.76 | $48,139 | -16.44% | ||
| 2024-01-31 | Sale | CEO | 60,000 0.0671% | $25.33 | $1.52M | +3.77% | ||
| 2024-01-03 | Sale | Chief Legal Officer | 1,907 0.0022% | $26.42 | $50,383 | -1.99% | ||
| 2023-11-20 | Sale | Chief Legal Officer | 10,000 0.0135% | $30.50 | $305,000 | -16.73% |